Webinar with live Q&A on modern small molecule drug discovery

Krakow, Poland – January 20, 2021 – Selvita will launch the Selvita Drug Discovery Webinar series, where experts will discuss strategies and technologies in small molecule drug discovery.

Covington Advises AIM-listed Sensyne Health on £27.5m Fundraising and Strategic Deal

LONDON, 13 January 2021 – Covington advised Sensyne Health plc, a UK clinical artificial intelligence company listed on the London AIM market, on its £27.5 million equity fundraising. The fundraise consisted of a placing with institutional investors, a subscription by directors and senior management, and an open offer to the company's existing shareholders.

Investigating new treatment for schizophrenia as first Psychiatry Consortium funded project announced

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Acacia Pharma wins BEL Small Company of the Year for the second consecutive year

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

Testing Lab Data Reveals Spread of New Covid Variant Across the Country

Scientists at the Alderley Park Lighthouse Lab in Cheshire have revealed the speed and scale at which the new variant of the COVID virus is spreading through communities across the country

Cognate BioServices, and its gene therapy division Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe

Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project

CEO Update | Monday 18 January

Virtual J.P. Morgan week kicked off the year which felt very different to the traditional scrum with life sciences colleagues in and around downtown San Francisco...

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration

Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase

UK-EU trade and cooperation agreement – medicines regulation

The UK and EU negotiators reached agreement on the future relationship just days before the end of the Brexit transition period, ending UK’s participation in the EU’s Single Market and Customs Union. The UK-EU Trade and Cooperation Agreement concluded on 24 December 2020, was ratified by the UK Parliament on 30 December, provisionally applicable since 1 January 2021, as agreed with the European Commission and EU Member States pending European Parliament consent and Council decision by end of February.

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration

Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase